Growth is fuelled by increasing demand for advanced intracellular delivery solutions across gene therapy, oncology, and ...

Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...

GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction. Legend Biotech continues to invest in R&D to expand the ...

Join us for an exciting event filled with engaging activities and opportunities to connect. Here’s how you can get involved: Join Presentations: Attend our informative presentations! Visit Our Booths: ...